Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 10
Submit an article Journal homepage
523
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Plasma uric acid response to rasburicase: early marker for acute kidney injury in tumor lysis syndrome?

Emmanuel CanetMedical Intensive Care UnitCorrespondence[email protected]
,
Morgane CheminantMedical Intensive Care Unit
,
Lara ZafraniMedical Intensive Care Unit
,
Catherine ThieblemontHematology Department, Saint-Louis University Hospital, Paris, France
,
Lionel GalicierHematology Department, Saint-Louis University Hospital, Paris, France
,
Etienne LenglineHematology Department, Saint-Louis University Hospital, Paris, France
,
David SchnellMedical Intensive Care Unit
,
Danielle ReuterMedical Intensive Care Unit
,
Michael DarmonMedical Intensive Care Unit, Saint-Etienne University Hospital, Saint-Etienne, France
,
Benoit SchlemmerMedical Intensive Care Unit;School of Medicine, Université Paris-Diderot, Sorbonne Paris-Cité, Paris, France
&
Elie AzoulayMedical Intensive Care Unit;School of Medicine, Université Paris-Diderot, Sorbonne Paris-Cité, Paris, France
 show all
Pages 2362-2367 | Received 01 Aug 2013, Accepted 07 Dec 2013, Published online: 24 Feb 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Elisa Russo & Francesca Viazzi. (2021) Relationship between uric acid and kidney function in adults at risk for tumor lysis syndrome. Leukemia & Lymphoma 62:13, pages 3067-3069.
Read now
Heather A. Personett, Erin F. Barreto, Kristen B. McCullough, Ross Dierkhising, Nelson Leung & Thomas M. Habermann. (2019) Impact of early rasburicase on incidence of clinical tumor lysis syndrome in lymphoma. Leukemia & Lymphoma 60:9, pages 2271-2277.
Read now
Jennifer Dinnel, Bonny L Moore, Brent M Skiver & Prithviraj Bose. (2015) Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy. Core Evidence 10, pages 23-38.
Read now

Articles from other publishers (10)

Suet Ying Lam, Eugene Yu-hin Chan, Frankie Wai Tso Cheng, Alison Lap Tak Ma & Shau Yin Ha. (2023) Acute kidney injury in children with haematological malignancy: a territory-wide study. Pediatric Nephrology.
Crossref
Moustafa Abdel-Nabey, Anis Chaba, Justine Serre, Etienne Lengliné, Elie Azoulay, Michael Darmon & Lara Zafrani. (2022) Tumor lysis syndrome, acute kidney injury and disease-free survival in critically ill patients requiring urgent chemotherapy. Annals of Intensive Care 12:1.
Crossref
Shohei Kikuchi, Makiko Muro, Yusuke Kamihara, Akinori Wada, Jun Murakami, Yoshimi Nabe, Tomoki Minemura & Tsutomu Sato. (2022) Massive hyperphosphatemia in clinical tumor lysis syndrome during prophylactic rasburicase use: risk factors and treatment options. International Cancer Conference Journal 12:1, pages 69-74.
Crossref
Marie Lemerle, Aline Schmidt, Valérie Thepot-Seegers, Achille Kouatchet, Valérie Moal, Melina Raimbault, Corentin Orvain, Jean-François Augusto & Julien Demiselle. (2022) Serum phosphate level and its kinetic as an early marker of acute kidney injury in tumor lysis syndrome. Journal of Nephrology 35:6, pages 1627-1636.
Crossref
Arpan Choudhary, Supriya Basu, Sujit K. Dey, Jayanta K. Rout, Ranjit K. Das & Ranjan K. Dey. (2018) Association and prognostic value of serum Cystatin C, IL-18 and Uric acid in urological patients with acute kidney injury. Clinica Chimica Acta 482, pages 144-148.
Crossref
Urshila Durani, Nilay D. Shah & Ronald S. Go. (2017) In-Hospital Outcomes of Tumor Lysis Syndrome: A Population-Based Study Using the National Inpatient Sample. The Oncologist 22:12, pages 1506-1509.
Crossref
Young-Woo Jeon, Dae-Hun Kwak, Sung-Soo Park, Jae-Ho Yoon, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Seok Lee, Chang-Ki Min, Jong-Wook Lee, Woo-Sung Min & Seok-Goo Cho. (2017) Effectiveness of Single-dose Rasburicase in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome. Clinical Lymphoma Myeloma and Leukemia 17:9, pages 595-603.
Crossref
A.-S. Vasseur & A.-S. Moreau. (2017) Analyse et critique des recommandations britanniques 2015 de prise en charge du syndrome de lyse tumorale de l’adulteAnalysis of the British guidelines 2015 for the management of adult tumor lysis syndrome. Médecine Intensive Réanimation.
Crossref
F. Vincent, A. Dupré, C. Mousseaux, C. Bornstain & M. Darmon. (2016) Febuxostat and tumor lysis syndrome: an indication that remains unclear. International Journal of Clinical Oncology 22:3, pages 605-606.
Crossref
A. Dupré, C. Mousseaux, A. Bouguerba, S. Ayed, J. Barchazs, M. Boukari, D. Goldgran-Toledano, C. Bornstain & F. Vincent. (2017) Analyse des recommandations britanniques 2015 sur la prévention et la prise en charge du syndrome de lyse tumorale. La Revue de Médecine Interne 38:1, pages 36-43.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.